Genéricos Ortho Micronor

NORETHINDRONE
(Micronor, Norlutin, Nor-Q.D.)
Norethindrone is a synthetic progestin that is used as an oral contraceptive (when formulated with an estrogenic compound) and in treatment of menstrual disorders. The dose used to treat endometriosis (up to 15 mg/d) is much greater than that currently used in oral contraceptives (0.4-2.5 mg/d).

Teratogenic Risk
Magnitude of teratogenic risk to child born after exposure during gestation:
Non-genital congenital anomalies: None.
Virilization of female fetus with large doses (used to treat endometriosis): Small.
Virilization of female fetus with small doses (used in oral contraceptives): None.
Quality and quantity of data on which risk estimate is based:
Non-genital congenital anomalies: Fair.
Virilization of female fetus with large doses (used to treat endometriosis): Fair.
Virilization of female fetus with small doses (used in oral contraceptives): Fair.

Maternal use of large doses of norethindrone during pregnancy has associated with the occurrence of masculinization of the external Italia in female infants. The genital anomalies observed include various degrees of clitoral hypertrophy with or without labioscrotal fusion. Internal genitalia and pubertal development are not affected. Labioscrotal fusion is associated with exposure between the seventh and thirteenth week of gestation, but clitoral hypertrophy can develop with exposure at this time or later in pregnancy. The frequency of genital virilization among daughters of women who took norethindrone during pregnancy in doses similar to or greater than those used to treat endometriosis was 13% and 19% in clinical series of 39 and 82 female infants, respectively.
The overall frequency of congenital anomalies was not significantly greater than expected among the children of 132 women who took norethindrone during the first four lunar months of pregnancy or of 148 women who took this drag anytime in pregnancy in a large epidemiological study. In another study, maternal use of norethindrone during pregnancy was not significantly increased among 171 children with various congenital anomalies. Similarly, the frequency of hormonal pregnancy tests using norethindrone and ethinyl estradiol (an estrogenic agent) during the second month of pregnancy was not increased among the mothers of 194 infants with major malformations or 551 infants with minor congenital anomalies.
Masculinization of the genitalia of female offspring can be induced in several species of experimental animals by treatment of the mother with norethindrone in high doses during pregnancy.
Studies in nonhuman primates, mice, and rabbits suggest that treatment of pregnant women with norethindrone in usual therapeutic or contraceptive doses is unlikely to increase the children's risk of non-genital congenital anomalies greatly.

Risk Related to Breast-feeding
Norethindrone is excreted in breast milk. The amount of norethindrone that the nursing infant would be expected to ingest is <1-24% of the lowest weight-adjusted dose used for oral contraception.
Norethindrone concentrations ranging from 0.07-0.42 ng/mL were measured in the serum of 15 breast-fed infants whose mothers took an oral contraceptive containing norethindrone. These levels of norethindrone were between 4-25% of those found in the maternal serum. In another study, no norethindrone was found in the serum of breast-fed infants whose mothers had been given an intramuscular injection of norethindrone.
Maternal use of norethindrone as a contraceptive during lactation had no adverse effects on growth or development of infants followed up to one year of age.
WOMEN’S HEALTH

FEMALE SEX GLANDS: OVARIAN DEFICIENCY
If the ovary is not adequate, or if it is absent following surgical removal, an insufficient secretion of the female sex hormones occurs. Absence of such hormones is associated with a disappearance of the usual menstrual flow. Development of the body is complete and the characteristics of women which are peculiar to the sex disappear.
As with a deficiency of the male sex hormone, absence of ovarian secretion results in overgrowth of the long bones, which fail to close their points of growth during adolescence. An insufficiency of ovarian secretion may lead to failure of the sexual organs to develop, so that they appear infantile in type. Associated is a lack of development of the breast and a lack of the usual growth of hair under the arms and around the sex organs.
If there is an adequate amount of female sex hormone up to the time of puberty and a failure to secrete thereafter, the symptoms are different, because the child will have achieved rather full growth by the time it comes to adolescence.
Fortunately, substitutes for the usual hormones have been found. These can be prescribed by the doctor in amounts as needed, and thus cause a return to normal conditions.
The function of the ovary is dependent on hormones that come from the pituitary or master gland in the brain. Failure of the pituitary gland to send its hormones will result in failure of the ovary to develop normally. With this comes lack of menstruation, lack of development of the breasts and delay in appearance of the other secondary female characteristics.
*2/318/5*
WOMEN’S HEALTH

P. Após clicar no botão "Adicionar ao Carrinho" entro noutro site, porquê?

R. Todas as operações de compra de Genéricos Ortho Micronor (Norethindrone acetate 5mg) são realizadas no nosso servidor de transacções seguras. Os seus dados são encriptados com segurança e estão protegidos contra acessos não autorizados.

P. O que acontece depois de eu efectuar uma encomenda de Genéricos Ortho Micronor (Norethindrone acetate 5mg)?

R. Uma vez que o seu pedido foi aprovado, ele será encaminhado para a farmácia para ser despachado e enviado do mesmo dia. Nós iremos notificá-lo por e-mail quando sua ordem foi processada. Para mais informações sobre o envio poderá consultar aqui.

P. Como funciona a política de privacidade?

R. Estamos totalmente dedicados à sua privacidade e segurança. Por favor, consulte a política de privacidade actual na secção Termos e Condições da página da encomenda. Certifique-se de que o nosso sistema de pedidos on-line utiliza a mais recente tecnologia de encriptação de segurança para garantir que a sua informação do cartão de crédito é apresentada de forma segura e com um maior nível de protecção. Todos os nossos sistemas informáticos são submetidos a controlos de segurança regulares para garantir que o nosso sistema de encomendas está devidamente protegido.

P. Como posso controlar a minha encomenda de Genéricos Ortho Micronor (Norethindrone acetate 5mg)?

R. Poderá usar um serviço de estafetas pagando 20 dólares extra.

P. Como poderei cancelar a minha encomenda de Genéricos Ortho Micronor (Norethindrone acetate 5mg)?

R. Consulte a Política de Reembolso

P. Poderão informar-me se eu deveria estar a tomar Genéricos Ortho Micronor (Norethindrone acetate 5mg)? Ou, será que vai funcionar comigo?

R. Nós não podemos ajudá-lo em qualquer questão acerca deste assunto. Não deverá tomar nenhuma medicação sem consultar previamente um médico.

P. Como funciona a política de devoluções?

R. Por lei, lamentamos mas não nos é permitido aceitar fármacos devolvidos. Se a sua compra tiver algum defeito, teremos o maior prazer em substituí-lo sem nenhum custo adicional.

P. E quanto à importação de Genéricos Ortho Micronor (Norethindrone acetate 5mg) para o meu país?

R. A importação de medicamentos de prescrição é legal na maioria dos países (incluindo os E.U.A, Reino Unido, França, Espanha, Hong Kong, Japão e Coreia) desde que o medicamento seja para uso pessoal e não seja uma substância controlada. Se tiver dúvidas sobre a situação no seu país, consulte a sua estação de Correios.